Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 2022 Global Investment Conference on May 23-26PRNewsWire • 05/19/22
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/13/22
CoDiagnostics, Inc. (CODX) Q1 Earnings and Revenues Beat EstimatesZacks Investment Research • 05/12/22
Co-Diagnostics reports record 1Q revenue as company looks to expand into new markets and innovative molecular diagnostics solutionsProactive Investors • 05/12/22
Co-Diagnostics, Inc. to Host Booth at Medical Fair Brasil 2022 in São Paulo on May 3-6PRNewsWire • 05/03/22
Why the Earnings Surprise Streak Could Continue for CoDiagnostics, Inc. (CODX)Zacks Investment Research • 04/26/22
Co-Diagnostics, Inc. to Host Booth at ECCMID 2022 in Lisbon, Portugal on April 23-26PRNewsWire • 04/22/22
Co-Diagnostics says its CoSara Diagnostics Indian joint venture has received clearance to manufacture and sell its Hepatitis C Viral (HCV) Load Kit as an in vitro diagnosticProactive Investors • 04/19/22
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis C Viral Load TestPRNewsWire • 04/19/22
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/24/22
Co-Diagnostics clocks up $97.9M in full year 2021 revenue on the strength of Logix Smart COVID-19 test salesProactive Investors • 03/24/22
Co-Diagnostics, Inc. to Present at MarketsandMarkets Conference on March 23-24 in London, EnglandPRNewsWire • 03/22/22
CoDiagnostics, Inc. (CODX) Surges 13.1%: Is This an Indication of Further Gains?Zacks Investment Research • 03/16/22
Co-Diagnostics, Inc. Announces Authorization of $30 Million Share Repurchase ProgramPRNewsWire • 03/15/22
CO-DIAGNOSTICS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 EARNINGS RELEASE DATE AND WEBCASTPRNewsWire • 03/14/22